What’s Propelling Ventas, Inc. to Increase So Much?

 What's Propelling Ventas, Inc. to Increase So Much?

In today’s session Ventas, Inc. (VTR) registered an unusually high (1,111) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the December, 2016 call, expecting serious VTR increase. With 1,111 contracts traded and 6214 open interest for the Dec, 16 contract, it seems this is a quite bullish bet. The option with symbol: VTR161216C00060000 closed last at: $1.65 or 8.3% down. About 130,511 shares traded hands. Ventas, Inc. (NYSE:VTR) has declined 4.86% since April 20, 2016 and is downtrending. It has underperformed by 9.41% the S&P500.

Ventas, Inc. (NYSE:VTR) Ratings Coverage

Out of 12 analysts covering Ventas Inc. (NYSE:VTR), 1 rate it a “Buy”, 0 “Sell”, while 11 “Hold”. This means 8% are positive. Ventas Inc. has been the topic of 30 analyst reports since July 27, 2015 according to StockzIntelligence Inc. The company was initiated on Tuesday, July 26 by Raymond James. UBS maintained it with “Neutral” rating and $71 target price in Tuesday, August 23 report. The stock of Ventas, Inc. (NYSE:VTR) has “Hold” rating given on Tuesday, February 16 by Stifel Nicolaus. The stock of Ventas, Inc. (NYSE:VTR) earned “Buy” rating by Mizuho on Friday, September 4. The firm has “Neutral” rating given on Thursday, March 24 by Goldman Sachs. The rating was initiated by Argus Research on Wednesday, July 13 with “Hold”. UBS maintained the shares of VTR in a report on Friday, May 20 with “Neutral” rating. Barclays Capital initiated the stock with “Equal-Weight” rating in Wednesday, January 6 report. BMO Capital Markets upgraded it to “Outperform” rating and $74 target price in Monday, July 27 report. The stock of Ventas, Inc. (NYSE:VTR) earned “Equal Weight” rating by Barclays Capital on Monday, May 2.

According to Zacks Investment Research, “Ventas, Inc. is a healthcare real estate investment trust.”

Insitutional Activity: The institutional sentiment increased to 1.33 in Q2 2016. Its up 0.07, from 1.26 in 2016Q1. The ratio is positive, as 40 funds sold all Ventas, Inc. shares owned while 189 reduced positions. 58 funds bought stakes while 231 increased positions. They now own 309.67 million shares or 1.99% less from 315.96 million shares in 2016Q1.
Qci Asset Mngmt owns 186,061 shares or 1.91% of their US portfolio. Huntington Bancshares last reported 0% of its portfolio in the stock. Pggm Invests reported 3.78 million shares or 1.41% of all its holdings. Retail Bank Of America Corp De last reported 0.31% of its portfolio in the stock. Texas Permanent School Fund last reported 0.11% of its portfolio in the stock. Commerzbank Aktiengesellschaft Fi last reported 0.02% of its portfolio in the stock. Gerstein Fisher accumulated 0.07% or 7,651 shares. Gilman Hill Asset Management Llc accumulated 2.02% or 67,814 shares. Asset Mngmt Inc holds 0.12% or 41,662 shares in its portfolio. Louisiana State Employees Retirement System holds 22,200 shares or 0.09% of its portfolio. Axa holds 124,413 shares or 0.04% of its portfolio. Ameriprise accumulated 0.03% or 696,055 shares. Brown Brothers Harriman And has 40 shares for 0% of their US portfolio. Carroll Finance Assoc Inc last reported 10,277 shares in the company. The New York-based Rafferty Asset Mgmt Llc has invested 0.18% in Ventas, Inc. (NYSE:VTR).

Insider Transactions: Since August 2, 2016, the stock had 0 insider buys, and 4 selling transactions for $18.19 million net activity. Cobb John D. sold $4.50 million worth of stock. $807,562 worth of Ventas, Inc. (NYSE:VTR) shares were sold by CAFARO DEBRA A. The insider RINEY T RICHARD sold 169,450 shares worth $12.37M. Liebbe Gregory R sold $508,225 worth of stock.

Ventas, Inc. is a healthcare real estate investment trust with its properties located throughout the United States, Canada and the United Kingdom. The company has a market cap of $21.17 billion. The Firm operates through three divisions: triple-net leased properties, senior living activities and MOB operations. It has a 38.29 P/E ratio. In its triple-net leased properties segment, the Company acquires and owns seniors housing and healthcare properties throughout the United States and the United Kingdom.

VTR Company Profile

Ventas, Inc., incorporated on June 22, 1987, is a healthcare real estate investment trust (REIT) with its properties located throughout the United States, Canada and the United Kingdom. The Firm operates through three divisions: triple-net leased properties, senior living activities and medical office building (MOB) operations. In its triple-net leased properties segment, the Company acquires and owns seniors housing and healthcare properties throughout the United States and the United Kingdom. Through its senior living activities segment, the Company invests in seniors housing communities throughout the United States and Canada, and engages independent operators to manage approximately 304 of its seniors housing communities. In its MOB activities segment, the Company primarily acquires, owns, develops, leases and manages MOBs. The Firm primarily invests in seniors housing and healthcare properties through acquisitions and leases its properties to unaffiliated tenants or operates them through independent third-party managers. It leases approximately 575 properties to various healthcare operating companies under triple-net or absolute-net leases that obligate the tenants to pay all property-related expenses, including maintenance, utilities, repairs, taxes, insurance and capital expenditures.

More news for Ventas, Inc. (NYSE:VTR) were recently published by: Reuters.com, which released: “BRIEF-Kindred announces agreements with Ventas Inc” on November 14, 2016. Seekingalpha.com‘s article titled: “What Does ‘TrumpCare’ Mean For Ventas?” and published on November 14, 2016 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment